← Back to Search

Behavioral Intervention

bpMedManage-S for Mild Cognitive Impairment

N/A
Recruiting
Led By Kathleen Insel, PhD
Research Sponsored by University of Arizona
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up week 4, week 12
Awards & highlights

Study Summary

This trial is testing the effectiveness of a smartphone app in helping older adults with mild cognitive impairment to better adhere to their high blood pressure medications. 100 participants will be recruited and split into two groups,

Who is the study for?
This trial is for older adults with mild cognitive impairment (MCI) who also have high blood pressure. Participants should be able to use a smartphone and willing to be monitored for their medication adherence over 16 weeks.Check my eligibility
What is being tested?
The MedManage study tests a smartphone app designed to help manage hypertension medications. There are two groups: one uses the app with reminders and education (MedManage-S), while the other receives only educational information (MedManage-P).See study design
What are the potential side effects?
Since this trial involves using digital technology rather than medication, there are no direct medical side effects. However, participants may experience frustration or difficulty if they're not tech-savvy.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~week 4, week 12
This trial's timeline: 3 weeks for screening, Varies for treatment, and week 4, week 12 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in medication adherence measured by the Medication Event Monitoring System (MEMS® Cap)
Change in self-reported medication adherence measured by the Medication Adherence Report Scale-5 (MARS-5© Professor Rob Horne)
Secondary outcome measures
Change in Systolic and/or Diastolic blood pressure, as measured by taking blood pressure readings
Change in hypertension knowledge measured by the Hypertension Knowledge-Level Scale
System Usability measured by the System Usability Scale
Other outcome measures
Opinion Interview

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: bpMedManage-SExperimental Treatment1 Intervention
Intervention group will use a smartphone application with medication reminders plus receive education with standardized information on hypertension and antihypertensive medications on the education portal. They will complete immediate outcomes assessment 4 weeks after the beginning of the intervention and follow-up outcomes 12 weeks after the beginning of intervention.
Group II: bpMedManage-PActive Control1 Intervention
Participants in the bpMedManage-P group will use a smartphone to receive education with standardized information on hypertension and antihypertensive medications on the education portal. They will complete immediate outcomes assessment 4 weeks after the beginning of the intervention and follow-up outcomes 12 weeks after the beginning of intervention.

Find a Location

Who is running the clinical trial?

University of Illinois at Urbana-ChampaignOTHER
189 Previous Clinical Trials
37,285 Total Patients Enrolled
University of ArizonaLead Sponsor
515 Previous Clinical Trials
148,614 Total Patients Enrolled
Kathleen Insel, PhDPrincipal InvestigatorUniversity of Arizona

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any vacancies available for patients to participate in this trial?

"Per clinicaltrials.gov, this research endeavor is actively seeking volunteers. The trial was initially uploaded on February 29th, 2024 and last revised on March 11th, 2024."

Answered by AI

What is the current number of individuals involved in this medical study?

"Yes, the details on clinicaltrials.gov indicate that this investigation is presently seeking candidates. The trial was first made available for viewing on February 29th, 2024 and most recently revised on March 11th, 2024. A total of 100 individuals are being sought across two designated sites."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
bpMedManage: Digital Technology to Support Adherence to Hypertension Medications
Kathleen Insel 2024. "bpMedManage: Digital Technology to Support Adherence to Hypertension Medications". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06307574.
All > Tucson
~67 spots leftby May 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top